this post was submitted on 09 Sep 2023
89 points (100.0% liked)
U.S. News
2244 readers
3 users here now
News about and pertaining to the United States and its people.
Please read what's functionally the mission statement before posting for the first time. We have a narrower definition of news than you might be accustomed to.
Guidelines for submissions:
- Post the original source of information as the link.
- If there is a paywall, provide an archive link in the body.
- Post using the original headline; edits for clarity (as in providing crucial info a clickbait hed omits) are fine.
- Social media is not a news source.
For World News, see the News community.
This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.
founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
JFC. There's an opioid shortage too and for the same apparent reason: the federal government setting limits on manufacturers.
I have cancer and have been on oxycodone daily for many months now. Last time I needed a refill, I almost couldn't get any in time before running out. Got it literally the night I took my last one. Can you imagine dealing with cancer pain AND opioid withdrawal symptoms at the same time? Why should I have to deal with that?
And why should all the families dealing with ADHD have to deal with shortages of drugs to treat that? This whole situation is fucking absurd.
I don't know much about the opioid shortage, but for Adderall it seems to be more complicated than just the quotas.... https://www.bloomberg.com/news/newsletters/2023-02-28/are-adderall-dea-quotas-contributing-to-the-shortage
If a manufacturer asks for an increased quota and the DEA denies it, they have to do so publicly, with a notice. Guess what, no notices.
Another source:
https://www.livemint.com/news/world/whats-behind-shortages-of-adderall-ozempic-and-other-meds-in-us-11682897998433.html
And another https://www.painnewsnetwork.org/stories/2023/8/3/fda-and-dea-leaders-call-for-more-adhd-meds-but-ignore-rx-opioid-shortages